Evolent Health Company Profile (NYSE:EVH)

About Evolent Health (NYSE:EVH)

Evolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company's platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company's services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company's technology platform that aggregates and analyzes data, manages care workflows and engages patients.

Industry, Sector and Symbol:

Sector: Computer and Technology
Industry: Medical Software & Technology Services
Sub-Industry: N/A
Symbol: NYSE:EVH
CUSIP: N/A
Web: www.evolenthealth.com

Capitalization:

Market Cap: $1.61316 billion
Outstanding Shares: 57,724,000

Average Prices:

50 Day Moving Avg: $25.91
200 Day Moving Avg: $22.05
52 Week Range: $14.50 - $27.50

P/E:

Trailing P/E Ratio: N/A
Foreward P/E Ratio: 1,302.50
P/E Growth: -2.14

Sales & Book Value:

Annual Revenue: $310.98 million
Price / Sales: 4.84
Book Value: $13.16 per share
Price / Book: 1.98

Profitability:

EBIDTA: ($50,960,000.00)
Net Margins: -17.69%
Return on Equity: -7.06%
Return on Assets: -5.81%

Debt:

Debt-to-Equity Ratio: 0.13%
Current Ratio: 2.08%
Quick Ratio: 2.08%

Misc:

Average Volume: 1.04 million shs.
Beta: 1.25
Short Ratio: 11.19

Frequently Asked Questions for Evolent Health (NYSE:EVH)

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How were Evolent Health's earnings last quarter?

Evolent Health, Inc (NYSE:EVH) issued its earnings results on Tuesday, May, 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.15) by $0.11. The firm earned $106.80 million during the quarter, compared to the consensus estimate of $104.38 million. Evolent Health had a negative return on equity of 7.06% and a negative net margin of 17.69%. The company's revenue for the quarter was up 116.2% compared to the same quarter last year. During the same period last year, the firm posted ($0.16) earnings per share. View Evolent Health's Earnings History.

Where is Evolent Health's stock going? Where will Evolent Health's stock price be in 2017?

13 analysts have issued twelve-month price targets for Evolent Health's shares. Their forecasts range from $26.00 to $35.00. On average, they anticipate Evolent Health's stock price to reach $30.10 in the next twelve months. View Analyst Ratings for Evolent Health.

What are analysts saying about Evolent Health stock?

Here are some recent quotes from research analysts about Evolent Health stock:

1. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (5/4/2017)
2. Cantor Fitzgerald analysts commented, "4Q16 results were solid. Adjusted 4Q16 revenue of $90 million (+92.6% y/y) was above consensus expectations of $85.3 million. Revenue included contributions from Valence and Aldera. Revenue growth was driven by contributions from Valence and Aldera and by an increase in the number of lives on the company’s platform. The number of lives grew 181.5% y/y, reaching about 2.0 million lives in 4Q16. EVH also added another 600,000 lives to the platform in January 2017. Adjusted transformation revenue of $12.1 million increased 12% y/y. Transformation revenue can fluctuate quarter-to-quarter due to the timing of customer contracts and the scope of delivery. Adjusted platform and operation revenue of $77.9 million (+116.8%) benefited from an increased number of lives on the platform. Average PMPM was $12.87 in 4Q16 vs. $16.70." (3/1/2017)

Who are some of Evolent Health's key competitors?

Some companies that are related to Evolent Health include HealthEquity (HQY), Allscripts Healthcare Solutions (MDRX), Omnicell (OMCL), Emis Group Plc (EMIS), Castlight Health, inc. (CSLT), NantHealth (NH), Craneware plc (CRW), Simulations Plus (SLP), Tabula Rasa Healthcare (TRHC), Fluidigm Corporation (FLDM), Medical Transcription Billing, Corp. (MTBC), Constellation Healthcare Tech (CHT) and Press Ganey Holdings (PGND).

Who are Evolent Health's key executives?

Evolent Health's management team includes the folowing people:

Seth Blackley, President
Frank John Williams, Chief Executive Officer, Director
Nicholas P. McGrane, Chief Financial Officer
Thomas Peterson III, Chief Operating Officer
Charles W. Pomeroy Jr., Chief Technology Officer
Lydia Stone, Principal Accounting Officer, Corporate Controller
Jonathan D. Weinberg, General Counsel
Dave Thornton, Chief Talent Officer
Steven J. Wigginton, Chief Development Officer
David Farner, Director

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who owns Evolent Health stock?

Evolent Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Peregrine Capital Management LLC (1.71%), Handelsbanken Fonder AB (0.42%), White Pine Investment CO (0.17%), Handelsinvest Investeringsforvaltning (0.15%), CWM LLC (0.13%) and US Bancorp DE (0.03%). Company insiders that own Evolent Health stock include Board Co Advisory, Chad Pomeroy, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Michael D'amato, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc and Upmc. View Institutional Ownership Trends for Evolent Health.

Who sold Evolent Health stock? Who is selling Evolent Health stock?

Evolent Health's stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC and White Pine Investment CO. Company insiders that have sold Evolent Health stock in the last year include Board Co Advisory, Chad Pomeroy, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc and Upmc. View Insider Buying and Selling for Evolent Health.

Who bought Evolent Health stock? Who is buying Evolent Health stock?

Evolent Health's stock was acquired by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Handelsinvest Investeringsforvaltning, CWM LLC, Fox Run Management L.L.C., US Bancorp DE, Bank of Montreal Can and Gradient Investments LLC. View Insider Buying and Selling for Evolent Health.

How do I buy Evolent Health stock?

Shares of Evolent Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Evolent Health's stock price today?

One share of Evolent Health stock can currently be purchased for approximately $26.05.

MarketBeat Community Rating for Evolent Health (NYSE EVH)

Community Ranking:		3.7 out of 5 ( )
Outperform Votes:		191 (Vote Outperform)
Underperform Votes:		67 (Vote Underperform)
Total Votes:		258

MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Evolent Health (NYSE:EVH) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	12 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:	Buy (Score: 3.08)
Consensus Price Target:	$30.10 (15.55% upside)

Analysts' Ratings History for Evolent Health (NYSE:EVH)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
6/28/2017	Cowen and Company	Reiterated Rating	Outperform	$35.00	Low
6/19/2017	Leerink Swann	Reiterated Rating	Outperform	$30.00 -> $32.00	Low
6/14/2017	Robert W. Baird	Reiterated Rating	Outperform	$30.00 -> $35.00	Medium
4/13/2017	Jefferies Group LLC	Reiterated Rating	Buy	$28.00	Low
3/14/2017	CIBC	Initiated Coverage	Outperform -> Outperform		Low
3/13/2017	Oppenheimer Holdings, Inc.	Initiated Coverage	Outperform	$28.00	Low
3/8/2017	Goldman Sachs Group, Inc. (The)	Upgrade	Buy -> Conviction-Buy	$30.00	Medium
3/1/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$26.00	N/A
2/3/2017	Canaccord Genuity	Reiterated Rating	Buy	$31.00	N/A
1/13/2017	Wells Fargo & Company	Upgrade	Market Perform -> Outperform		N/A
10/28/2016	J P Morgan Chase & Co	Initiated Coverage	Overweight	$30.00	N/A
9/30/2016	William Blair	Reiterated Rating	Outperform		N/A
8/5/2016	FBR & Co	Boost Price Target	Outperform	$24.00 -> $26.00	N/A

(Data available from 7/24/2015 forward)

Earnings History for Evolent Health (NYSE:EVH)

Earnings by Quarter for Evolent Health (NYSE:EVH)

Earnings History by Quarter for Evolent Health (NYSE EVH)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/9/2017	Q1 2017	($0.15)	($0.26)	$104.38 million	$106.80 million	View	Listen
2/28/2017	Q416	($0.20)	($0.35)	$84.98 million	$88.00 million	View	Listen
11/9/2016	Q316	($0.13)	($0.26)	$58.35 million	$60.20 million	View	Listen
8/4/2016	Q216	($0.16)	($0.12)	$51.96 million	$56.50 million	View	N/A
5/12/2016	Q116	($0.19)	($0.16)	$47.40 million	$49.50 million	View	Listen
2/25/2016	Q415	($0.21)	($0.05)	$43.73 million	$46.70 million	View	Listen
11/5/2015	Q315	($0.21)	($0.16)	$42.51 million	$43.30 million	View	N/A
8/6/2015	Q215	($0.37)	($1.00)	$157.50 million	$36.50 million	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Evolent Health (NYSE:EVH)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q2 2017	1	($0.11)	($0.11)	($0.11)
Q3 2017	1	($0.08)	($0.08)	($0.08)
Q4 2017	1	($0.03)	($0.03)	($0.03)

(Data provided by Zacks Investment Research)

Dividend History for Evolent Health (NYSE:EVH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for Evolent Health (NYSE:EVH)

Insider Ownership Percentage: 8.79%
Institutional Ownership Percentage: 69.03%

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Insider Trades by Quarter for Evolent Health (NYSE:EVH)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/10/2017	Nicholas Mcgrane	CFO	Sell	1,667	$25.42	$42,375.14
7/6/2017	Frank J. Williams	CEO	Sell	16,300	$24.76	$403,588.00
7/3/2017	Steve Wigginton	CEO	Sell	6,000	$25.07	$150,420.00
6/28/2017	Tpg Growth Ii Advisors, Inc.	Insider	Sell	4,279,325	$25.87	$110,706,137.75
6/15/2017	Seth Blackley	President	Sell	15,000	$25.22	$378,300.00
6/12/2017	Nicholas Mcgrane	CFO	Sell	1,667	$24.58	$40,974.86
6/7/2017	Nicholas Mcgrane	CFO	Sell	10,495	$26.95	$282,840.25
6/6/2017	Kenneth A. Samet	Director	Sell	4,000	$25.75	$103,000.00
6/6/2017	Steve Wigginton	CEO	Sell	959	$25.75	$24,694.25
5/19/2017	Cheryl Scott	Director	Sell	5,477	$23.51	$128,764.27
5/19/2017	Frank J. Williams	CEO	Sell	114,865	$24.30	$2,791,219.50
5/19/2017	Jonathan Weinberg	General Counsel	Sell	17,230	$24.30	$418,689.00
5/19/2017	Nicholas Mcgrane	CFO	Sell	47,508	$24.30	$1,154,444.40
5/19/2017	Thomas Peterson III	COO	Sell	57,433	$24.30	$1,395,621.90
5/19/2017	Tpg Growth Ii Advisors, Inc.	Insider	Sell	3,081,760	$24.30	$74,886,768.00
5/19/2017	Upmc	Major Shareholder	Sell	2,333,333	$24.30	$56,699,991.90
5/15/2017	Seth Blackley	President	Sell	15,000	$25.00	$375,000.00
5/15/2017	Thomas Peterson III	COO	Sell	83,108	$24.99	$2,076,868.92
5/10/2017	Nicholas Mcgrane	Insider	Sell	1,667	$24.28	$40,474.76
5/10/2017	Thomas Peterson III	COO	Sell	18,604	$25.00	$465,100.00
5/4/2017	Frank J Williams	CEO	Sell	16,300	$23.55	$383,865.00
5/3/2017	Jonathan Weinberg	General Counsel	Sell	15,000	$23.85	$357,750.00
5/1/2017	Steve Wigginton	CEO	Sell	6,000	$23.10	$138,600.00
5/1/2017	Upmc	Major Shareholder	Sell	403,644	$19.53	$7,883,167.32
4/19/2017	Nicholas Mcgrane	CFO	Sell	1,667	$22.52	$37,540.84
4/17/2017	Seth Blackley	President	Sell	15,000	$21.48	$322,200.00
4/6/2017	Frank J Williams	CEO	Sell	16,300	$22.03	$359,089.00
4/3/2017	Steve Wigginton	CEO	Sell	6,000	$23.15	$138,900.00
3/31/2017	Upmc	Major Shareholder	Sell	2,690,961	$19.53	$52,554,468.33
3/30/2017	Seth Blackley	President	Sell	15,000	$21.19	$317,850.00
3/28/2017	Board Co Advisory	Major Shareholder	Sell	2,118,078	$19.53	$41,366,063.34
3/24/2017	Nicholas Mcgrane	CFO	Sell	7,034	$22.50	$158,265.00
1/30/2017	Seth Blackley	President	Sell	15,000	$17.58	$263,700.00
1/17/2017	Seth Blackley	President	Sell	30,000	$17.98	$539,400.00
11/14/2016	Michael D'amato	Director	Buy	10,000	$17.18	$171,800.00
9/22/2016	Board Co Advisory	Major Shareholder	Sell	317,712	$22.50	$7,148,520.00
9/14/2016	Board Co Advisory	Major Shareholder	Sell	1,936,529	$22.50	$43,571,902.50
9/14/2016	Chad Pomeroy	Insider	Sell	55,180	$21.54	$1,188,577.20
9/14/2016	Frank J Williams	CEO	Sell	251,481	$21.54	$5,416,900.74
9/14/2016	Jonathan Weinberg	General Counsel	Sell	10,339	$21.54	$222,702.06
9/14/2016	Nicholas Mcgrane	CFO	Sell	21,205	$21.54	$456,755.70
9/14/2016	Seth Blackley	President	Sell	167,672	$21.54	$3,611,654.88
9/14/2016	Thomas Peterson III	COO	Sell	72,827	$21.54	$1,568,693.58
6/10/2015	Gary Piefer	Insider	Buy	2,000	$17.00	$34,000.00

(Data available from 1/1/2013 forward)

Headline Trends for Evolent Health (NYSE:EVH) Latest Headlines for Evolent Health (NYSE:EVH)

Source:

Date	Headline
	Head-To-Head Analysis: Simulations Plus (SLP) vs. Evolent Health (NYSE:EVH) www.americanbankingnews.com - July 21 at 12:06 PM
	Evolent Health Inc (EVH) Stock Rating Upgraded by BidaskClub www.americanbankingnews.com - July 16 at 3:22 PM
	$104.54 Million in Sales Expected for Evolent Health, Inc (EVH) This Quarter www.americanbankingnews.com - July 13 at 10:00 AM
	Nicholas Mcgrane Sells 1,667 Shares of Evolent Health, Inc (NYSE:EVH) Stock www.americanbankingnews.com - July 12 at 8:45 PM
	Evolent Health, Inc (NYSE:EVH) Expected to Post Earnings of -$0.13 Per Share www.americanbankingnews.com - July 12 at 12:06 AM
	Evolent Health, Inc (NYSE:EVH) Given Average Recommendation of "Buy" by Analysts www.americanbankingnews.com - July 11 at 10:48 AM
	Frank J. Williams Sells 16,300 Shares of Evolent Health, Inc (NYSE:EVH) Stock www.americanbankingnews.com - July 10 at 8:13 PM
	Evolent Health, Inc. – Value Analysis (NYSE:EVH) : July 10, 2017 finance.yahoo.com - July 10 at 6:23 PM
	Evolent Health, Inc. breached its 50 day moving average in a Bearish Manner : EVH-US : July 7, 2017 finance.yahoo.com - July 8 at 10:38 AM
	Steve Wigginton Sells 6,000 Shares of Evolent Health, Inc (EVH) Stock www.americanbankingnews.com - July 6 at 8:05 PM
	Tpg Growth Ii Advisors, Inc. Sells 4,279,325 Shares of Evolent Health, Inc (EVH) Stock www.americanbankingnews.com - June 30 at 7:16 PM
	Evolent Health's (EVH) "Outperform" Rating Reaffirmed at Cowen and Company www.americanbankingnews.com - June 28 at 12:40 PM
	What The Street Gets Wrong About Evolent Health, Cowen's 'Best Small-Mid Cap Idea' - Benzinga www.benzinga.com - June 28 at 3:23 AM
	Evolent Health (EVH) Is Heading Lower After Secondary Offering www.rttnews.com - June 24 at 5:26 PM
	Evolent Health (EVH) Prices 4.5M Follow-On Share Offering - Nasdaq www.nasdaq.com - June 23 at 5:42 PM
	Seth Blackley Sells 15,000 Shares of Evolent Health, Inc (EVH) Stock www.americanbankingnews.com - June 19 at 7:35 PM
	Evolent Health's (EVH) "Outperform" Rating Reaffirmed at Leerink Swann www.americanbankingnews.com - June 19 at 5:38 PM
	Evolent Health (EVH) PT Raised to $32 at Leerink Partners - StreetInsider.com www.streetinsider.com - June 19 at 1:23 PM
	Analysts Expect Evolent Health, Inc (EVH) Will Post Quarterly Sales of $104.54 Million www.americanbankingnews.com - June 17 at 7:44 AM
	Evolent Health, Inc (EVH) Receives Average Rating of "Buy" from Analysts www.americanbankingnews.com - June 16 at 9:02 AM
	-$0.13 Earnings Per Share Expected for Evolent Health, Inc (EVH) This Quarter www.americanbankingnews.com - June 15 at 10:20 PM
	ETFs with exposure to Evolent Health, Inc. : June 15, 2017 finance.yahoo.com - June 15 at 7:11 PM
	Evolent Health, Inc (EVH) CFO Sells $40,974.86 in Stock www.americanbankingnews.com - June 14 at 8:32 PM
	Robert W. Baird Reaffirms Outperform Rating for Evolent Health, Inc (EVH) www.americanbankingnews.com - June 14 at 5:20 PM
	Evolent Health Inc (EVH) CEO Sells $24,694.25 in Stock www.americanbankingnews.com - June 8 at 8:20 PM
	Evolent Health Inc (EVH) Director Kenneth A. Samet Sells 4,000 Shares www.americanbankingnews.com - June 8 at 7:52 PM
	Nicholas Mcgrane Sells 10,495 Shares of Evolent Health Inc (EVH) Stock www.americanbankingnews.com - June 8 at 7:28 PM
	Financial Review: Imprivata (IMPR) and Evolent Health (EVH) www.americanbankingnews.com - June 5 at 8:01 AM
	Robert W. Baird Initiates Coverage on Evolent Health Inc (EVH) www.americanbankingnews.com - June 1 at 6:10 PM
	Evolent Health, Inc. breached its 50 day moving average in a Bullish Manner : EVH-US : June 1, 2017 finance.yahoo.com - June 1 at 5:49 PM
	ETFs with exposure to Evolent Health, Inc. : May 30, 2017 finance.yahoo.com - May 30 at 4:59 PM
	Evolent Health to Participate in Upcoming Investor Conferences finance.yahoo.com - May 30 at 4:59 PM
	Evolent Health Inc (EVH) Stock Rating Upgraded by TheStreet www.americanbankingnews.com - May 25 at 2:42 PM
	Insider Selling: Evolent Health Inc (EVH) Director Sells 5,477 Shares of Stock www.americanbankingnews.com - May 23 at 8:19 PM
	Evolent Health Inc (EVH) General Counsel Jonathan Weinberg Sells 17,230 Shares www.americanbankingnews.com - May 23 at 7:47 PM
	Evolent Health Inc (EVH) COO Sells $1,395,621.90 in Stock www.americanbankingnews.com - May 23 at 7:27 PM
	Evolent Health Inc (EVH) Insider Sells $74,886,768.00 in Stock www.americanbankingnews.com - May 23 at 7:26 PM
	Insider Selling: Evolent Health Inc (EVH) CEO Sells $2,791,219.50 in Stock www.americanbankingnews.com - May 23 at 7:26 PM
	Evolent Health Inc (EVH) CFO Sells $1,154,444.40 in Stock www.americanbankingnews.com - May 23 at 7:26 PM
	Insider Selling: Evolent Health Inc (EVH) Major Shareholder Sells 2,333,333 Shares of Stock www.americanbankingnews.com - May 22 at 4:29 PM
	Evolent Health Inc (EVH) Receives Consensus Recommendation of "Buy" from Analysts www.americanbankingnews.com - May 22 at 8:22 AM
	ETFs with exposure to Evolent Health, Inc. : May 18, 2017 finance.yahoo.com - May 19 at 5:31 AM
	Evolent Health Inc (EVH) COO Thomas Peterson III Sells 83,108 Shares www.americanbankingnews.com - May 17 at 10:29 PM
	Insider Selling: Evolent Health Inc (EVH) President Sells 15,000 Shares of Stock www.americanbankingnews.com - May 17 at 7:47 PM
	Evolent Health (EVH) Prices 7M Follow-On Share Offering - Nasdaq www.nasdaq.com - May 17 at 5:03 PM
	Evolent Health (EVH) Prices 7M Share Upsized Secondary Offering at $24.65/Sh www.streetinsider.com - May 16 at 11:50 AM
	Evolent Health, Inc. Announces Pricing of Upsized Secondary Public Offering of Class A Common Stock finance.yahoo.com - May 16 at 11:50 AM
	Evolent Health, Inc. :EVH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 16, 2017 finance.yahoo.com - May 16 at 11:50 AM
	Q2 2017 Earnings Forecast for Evolent Health Inc Issued By Leerink Swann (EVH) www.americanbankingnews.com - May 15 at 7:58 AM
	Evolent Health Inc (EVH) COO Sells $465,100.00 in Stock www.americanbankingnews.com - May 12 at 10:50 PM